167 related articles for article (PubMed ID: 2571670)
1. Activation of peripheral blood T cells via the p75 interleukin 2 receptor.
Yagita H; Nakata M; Azuma A; Nitta T; Takeshita T; Sugamura K; Okumura K
J Exp Med; 1989 Oct; 170(4):1445-50. PubMed ID: 2571670
[TBL] [Abstract][Full Text] [Related]
2. Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes.
Zambello R; Cassatella MA; Trentin L; Bulian P; Siviero F; Feruglio C; Agostini C; Vespignani M; Chisesi T; Pizzolo G
Leukemia; 1991 Nov; 5(11):942-50. PubMed ID: 1835747
[TBL] [Abstract][Full Text] [Related]
3. Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor.
Levitt LJ; Nagler A; Lee F; Abrams J; Shatsky M; Thompson D
J Clin Invest; 1991 Jul; 88(1):67-75. PubMed ID: 1676038
[TBL] [Abstract][Full Text] [Related]
4. Activation of natural killer cells via the p75 interleukin 2 receptor.
Phillips JH; Takeshita T; Sugamura K; Lanier LL
J Exp Med; 1989 Jul; 170(1):291-6. PubMed ID: 2787381
[TBL] [Abstract][Full Text] [Related]
5. Expression and role of p75 interleukin 2 receptor on human monocytes.
Espinoza-Delgado I; Ortaldo JR; Winkler-Pickett R; Sugamura K; Varesio L; Longo DL
J Exp Med; 1990 May; 171(5):1821-6. PubMed ID: 2110244
[TBL] [Abstract][Full Text] [Related]
6. Independent expression of p55 and p75 interleukin-2 receptors (IL-2R) during intravenous or subcutaneous administration of recombinant interleukin-2 (rIL-2) by T-lymphocytes and natural killer cells.
Zambello R; Trentin L; Cerutti A; Enthammer C; Milani A; Franceschi T; Messina C; Cetto GL; Agostini C; Semenzato G
Cancer; 1994 Nov; 74(9):2562-9. PubMed ID: 7522954
[TBL] [Abstract][Full Text] [Related]
7. Generation of cytolytic activity with anti-CD3 monoclonal antibodies involves both IL-2-independent and -dependent components.
Stohl W; Tovar Z; Talal N
J Immunol; 1990 May; 144(10):3718-25. PubMed ID: 2139672
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of human T cells via anti-T cell receptor monoclonal antibody BMA031: distinct cellular events involving interleukin-2 receptor and lymphocyte function antigen 1.
Knobloch C; Diamantstein T; Flegel WA; Friedrich W
Cell Immunol; 1991 Nov; 138(1):150-64. PubMed ID: 1913834
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.
Weil-Hillman G; Voss SD; Fisch P; Schell K; Hank JA; Sosman JA; Sugamura K; Sondel PM
Cancer Res; 1990 May; 50(9):2683-91. PubMed ID: 1691679
[TBL] [Abstract][Full Text] [Related]
10. Cell membrane expression and functional role of the p75 subunit of interleukin-2 receptor in lymphoproliferative disease of granular lymphocytes.
Zambello R; Trentin L; Pizzolo G; Bulian P; Masciarelli M; Feruglio C; Agostini C; Raimondi R; Chisesi T; Semenzato G
Blood; 1990 Nov; 76(10):2080-5. PubMed ID: 2146981
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-2 receptor monoclonal antibodies have no effect on anti-CD3 monoclonal antibody-mediated cytotoxicity in CD3+ leukemic large granular lymphocytes.
Yoon HJ; Aprile JA; Loughran TP
Cell Immunol; 1990 Dec; 131(2):404-8. PubMed ID: 2146989
[TBL] [Abstract][Full Text] [Related]
12. Expression of the interleukin 2 receptor beta chain (p75) in renal transplantation--applicability of anti-interleukin-2 receptor beta chain monoclonal antibody.
Niguma T; Sakagami K; Kawamura T; Haisa M; Fujiwara T; Kusaka S; Uda M; Orita K
Transplantation; 1991 Aug; 52(2):296-302. PubMed ID: 1831304
[TBL] [Abstract][Full Text] [Related]
13. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.
Carson WE; Giri JG; Lindemann MJ; Linett ML; Ahdieh M; Paxton R; Anderson D; Eisenmann J; Grabstein K; Caligiuri MA
J Exp Med; 1994 Oct; 180(4):1395-403. PubMed ID: 7523571
[TBL] [Abstract][Full Text] [Related]
14. IL-2-dependent proliferation of murine T cells requires expression of both the p55 and p70 subunits of the IL-2 receptor.
Jankovic DL; Rebollo A; Kumar A; Gibert M; Thèze J
J Immunol; 1990 Dec; 145(12):4136-44. PubMed ID: 2258612
[TBL] [Abstract][Full Text] [Related]
15. Activation of leukemic large granular lymphocytes by interleukin-2 via the p75 interleukin-2 receptor.
Yoon HJ; Sugamura K; Loughran TP
Leukemia; 1990 Dec; 4(12):848-50. PubMed ID: 2147047
[TBL] [Abstract][Full Text] [Related]
16. Expression and role of interleukin-2 receptor beta chain on CD4-CD8- T cell receptor alpha beta+ cells [corrected].
Takeuchi Y; Tanaka T; Hamamura K; Sugimoto T; Miyasaka M; Yagita H; Okumura K
Eur J Immunol; 1992 Nov; 22(11):2929-35. PubMed ID: 1425918
[TBL] [Abstract][Full Text] [Related]
17. IL-7 regulation of cytotoxic lymphocytes: pore-forming protein gene expression, interferon-gamma production, and cytotoxicity of human peripheral blood lymphocytes subsets.
Smyth MJ; Norihisa Y; Gerard JR; Young HA; Ortaldo JR
Cell Immunol; 1991 Dec; 138(2):390-403. PubMed ID: 1834347
[TBL] [Abstract][Full Text] [Related]
18. Expression and functional role of the p75 interleukin 2 receptor chain on leukemic hairy cells.
Trentin L; Zambello R; Benati C; Cassatella M; Agostini C; Bulian P; Adami F; Carra G; Pizzolo G; Semenzato G
Cancer Res; 1992 Oct; 52(19):5223-8. PubMed ID: 1394125
[TBL] [Abstract][Full Text] [Related]
19. Expression of murine IL-2 receptor beta-chain on thymic and splenic lymphocyte subpopulations as revealed by the IL-2-induced proliferative response in human IL-2 receptor alpha-chain transgenic mice.
Hattori M; Okazaki H; Ishida Y; Onuma M; Kano S; Honjo T; Minato N
J Immunol; 1990 May; 144(10):3809-15. PubMed ID: 2332632
[TBL] [Abstract][Full Text] [Related]
20. Activation of the interleukin 2 pathway precedes CD3-T cell receptor expression in thymic development. Differential growth requirements of early and mature intrathymic subpopulations.
Toribio ML; De la Hera A; Marcos MA; Márquez C; Martínez C
Eur J Immunol; 1989 Jan; 19(1):9-15. PubMed ID: 2522051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
